Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Hviid Simonsen

Showing results (41-50 of 91) with videos related to

Pageof 10
Sort By:
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 17, 2025
Plasma biomarkers of amyloid, tau, astrogliosis, and axonal injury in a mixed memory clinic cohortHelena Sophia Gleerup, Anja Hviid Simonsen, Lana Grötschel, et al.
Clinical Chemistry and Laboratory Medicine|March 31, 2023
Measurement of amyloid-β 1-42 in cerebrospinal fluid: a comparison of the second generation Elecsys and INNOTESTKonstantinos Dimopoulos, Anja Hviid Simonsen, Mathias Holsey Gramkow, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 12, 2025
Influence of ethnicity on the diagnostic accuracy of plasma p-tau217 for the identification of Alzheimer's disease: A consecutive mixed memory clinic cohort studyDaniel Kjaergaard, T Rune Nielsen, Erik Stomrud, et al.
Dementia and Geriatric Cognitive Disorders|September 20, 2016
Cerebrospinal Fluid Amyloid Beta and Tau Concentrations Are Not Modulated by 16 Weeks of Moderate- to High-Intensity Physical Exercise in Patients with Alzheimer DiseaseCamilla Steen Jensen, Erik Portelius, Volkert Siersma, et al.
Neuroscience Applied|July 14, 2025
Associations between sleep quality and biomarkers for neurodegeneration - A longitudinal one-year case-control study of patients with bipolar disorder and healthy control individualsUlla Knorr, Anja Hviid Simonsen, Eva Letty Susanne Engström, et al.
Alzheimer'S & Dementia (New York, N. Y.)|August 19, 2025
The plasma p-tau217/BD-tau ratio improves biomarker short-term variability in memory clinic patientsFrederikke Kragh Clemmensen, Fernando Gonzalez-Ortiz, Mathias Holsey Gramkow, et al.
Journal of Affective Disorders|May 9, 2024
Cerebrospinal fluid synaptic biomarker changes in bipolar disorder - A longitudinal case-control studyUlla Knorr, Anja Hviid Simonsen, Johanna Nilsson, et al.
Journal of Neuroscience Methods|July 6, 2010
Proteomic investigations of the ventriculo-lumbar gradient in human CSFAnja Hviid Simonsen, Sara Bech, Inga Laursen, et al.
Journal of Alzheimer'S Disease : JAD|August 8, 2025
The Danish Dementia Research Centre: Integrating patient care, clinical research, and national educational servicesSteen Gregers Hasselbalch, Birgitte Bo Andersen, Patrick Ejlerskov, et al.
Proteomics. Clinical Applications|December 8, 2010
Sample handling for mass spectrometric proteomic investigations of human urineAnette Lykke Petri, Claus Høgdall, Ib Jarle Christensen, et al.
Pageof 10

Showing results (41-50 of 91) with videos related to

Sort By:
Pageof 10
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 17, 2025
Plasma biomarkers of amyloid, tau, astrogliosis, and axonal injury in a mixed memory clinic cohortHelena Sophia Gleerup, Anja Hviid Simonsen, Lana Grötschel, et al.
Clinical Chemistry and Laboratory Medicine|March 31, 2023
Measurement of amyloid-β 1-42 in cerebrospinal fluid: a comparison of the second generation Elecsys and INNOTESTKonstantinos Dimopoulos, Anja Hviid Simonsen, Mathias Holsey Gramkow, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 12, 2025
Influence of ethnicity on the diagnostic accuracy of plasma p-tau217 for the identification of Alzheimer's disease: A consecutive mixed memory clinic cohort studyDaniel Kjaergaard, T Rune Nielsen, Erik Stomrud, et al.
Dementia and Geriatric Cognitive Disorders|September 20, 2016
Cerebrospinal Fluid Amyloid Beta and Tau Concentrations Are Not Modulated by 16 Weeks of Moderate- to High-Intensity Physical Exercise in Patients with Alzheimer DiseaseCamilla Steen Jensen, Erik Portelius, Volkert Siersma, et al.
Neuroscience Applied|July 14, 2025
Associations between sleep quality and biomarkers for neurodegeneration - A longitudinal one-year case-control study of patients with bipolar disorder and healthy control individualsUlla Knorr, Anja Hviid Simonsen, Eva Letty Susanne Engström, et al.
Alzheimer'S & Dementia (New York, N. Y.)|August 19, 2025
The plasma p-tau217/BD-tau ratio improves biomarker short-term variability in memory clinic patientsFrederikke Kragh Clemmensen, Fernando Gonzalez-Ortiz, Mathias Holsey Gramkow, et al.
Journal of Affective Disorders|May 9, 2024
Cerebrospinal fluid synaptic biomarker changes in bipolar disorder - A longitudinal case-control studyUlla Knorr, Anja Hviid Simonsen, Johanna Nilsson, et al.
Journal of Neuroscience Methods|July 6, 2010
Proteomic investigations of the ventriculo-lumbar gradient in human CSFAnja Hviid Simonsen, Sara Bech, Inga Laursen, et al.
Journal of Alzheimer'S Disease : JAD|August 8, 2025
The Danish Dementia Research Centre: Integrating patient care, clinical research, and national educational servicesSteen Gregers Hasselbalch, Birgitte Bo Andersen, Patrick Ejlerskov, et al.
Proteomics. Clinical Applications|December 8, 2010
Sample handling for mass spectrometric proteomic investigations of human urineAnette Lykke Petri, Claus Høgdall, Ib Jarle Christensen, et al.
Pageof 10